Be Biopharma, Inc. ("Be Bio"), a clinical-stage company pioneering engineered B Cell Medicines (BCMs), today announced two key updates at the 66th ASH Annual Meeting in San Diego, CA. These updates ...
Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and ...
During the SITC presentation, Hanmi outlined the background, design, and clinical progress of BH3120 ... On November 25, Hanmi announced that it presented the research and clinical progress of BH3120 ...
The poster presenter is on hand to answer questions and provide additional details. Keep in mind that the poster needs to attract attention from 10 feet away so include a large, interesting photo or ...
During the SITC presentation, Hanmi outlined the background, design, and clinical progress of BH3120. Currently, a global Phase 1 clinical trial is underway in South Korea and the United States, ...
During the SITC presentation, Hanmi outlined the background, design, and clinical progress of BH3120. Currently, a global Phase 1 clinical trial is underway in South Korea and the United States ...